|
AU6587998A
|
|
Ligand/lytic peptide compositions and methods of use
|
|
IL114697D0
|
|
Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
|
|
US5773413A
|
|
Method of combating mammalian neoplasias, and lytic peptides therefor
|
|
IL113244D0
|
|
Method of combating mammalian neoplasia and lytic peptides therefor
|
|
WO9513085A1
|
|
Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
|
|
WO9513822A1
|
|
Modified arginine-containing lytic peptides and method of making the same by glyoxylation
|
|
WO9428921A1
|
|
Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
|
|
US5561107A
|
|
Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
|
